As of 2011, Aricept was the world's best-selling Alzheimer's disease treatment.[20] The first generic donepezil became available in November 2010 with the USFDA approval of a formulation prepared by Ranbaxy Labs.[21] In April 2011 a second generic formulation, from Wockhardt, received tentative USFDA marketing approval.[22]